融券方面，当日融券卖出0.00万股，净卖出0.00万股。 本文源自：金融界 作者：智投君 7月30日，沪深两融数据显示，华人健康获融资买入额0.53亿元，居两市第893位，当日融资偿还额0.52 亿元，净买入61.72万元。 最近三个交易日，28日-30日，华人健康分别获融资买入0.24亿元、0.17亿元、0.53亿元。 ...

7月30日，华人健康今日收盘15.01元，上涨5.48%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到39.72倍，创22天以来新低，总市值60.04亿元。 从行业市盈率排名来看，公司所处的医药商业行业市盈率平均44.76倍，行业中值30.23倍，华人健康排 名第22位。 截至2025年一季报，共有2家机构持仓华人健康，其中基金2家，合计持股数0.77万股，持股市值0.00亿 元。 安徽华人健康医药股份有限公司的主营业务是医药零售、代理及终端集采业务。公司的主要产品是中西 成药、中药饮片、保健品、医疗器械、特色原料药等。2024年度，公司营业收入再创新高，达45.32亿 元，比上年同期增长19.34%；归属于母公司所有者的净利润为1.38亿元，比上年同期增长20.09%；归属 于母公司所有者的扣除非经常性损益净利润1.29亿元，比上年同期增长21.81%，其中研发费用为 2,938.73万元，比上年同期增长21.46%。公司经营性现金流量持续改善，经营质量稳步提升。 作者：行情君 最新一期业绩显示，2025年一季报，公司实现营业收入12.67亿元，同比14.71%；净利润6122.23万元， ...

Group 1 - The stock price of Huaren Health closed at 15.01 yuan on July 30, an increase of 0.78 yuan from the previous trading day [1] - The opening price on the same day was 14.21 yuan, with a highest point of 15.83 yuan and a lowest point of 14.13 yuan, resulting in an intraday volatility of 11.95% [1] - The trading volume was 334,074 hands, with a total transaction amount of 499 million yuan [1] Group 2 - Huaren Health operates in the pharmaceutical commercial sector, with main businesses including pharmaceutical retail chains, wholesale, and logistics distribution [1] - The company is headquartered in Anhui and its business scope covers multiple regions across the country [1] - During intraday trading on July 30, Huaren Health experienced a rapid pullback, with a drop of over 2% within 5 minutes, and a transaction amount of 314 million yuan at that time [1] - The net inflow of main funds on that day was 21.02 million yuan [1]

天眼查商业履历信息显示，安徽华人健康医药股份有限公司，成立于2001年，位于合肥市，是一家以从 事零售业为主的企业。企业注册资本40001万人民币，实缴资本3888.89万人民币。公司法定代表人为何 家乐。 通过天眼查大数据分析，安徽华人健康医药股份有限公司共对外投资了18家企业，参与招投标项目33 次，知识产权方面有商标信息156条，专利信息21条，此外企业还拥有行政许可41个。 来源：金融界 金融界消息 截至2025年7月30日收盘，华人健康（301408）报收于15.01元，上涨5.48%，换手率 22.4%，成交量33.41万手，成交金额4.99亿元。 资金流向方面，今日主力资金净流入2101.58万元，占比成交额4.21%。其中，超大单净流入3121.25万 元、占成交额6.26%，大单净流出1019.67万元、占成交额2.04%，中单净流出流出2648.56万元、占成交 额5.31%，小单净流入546.98万元、占成交额1.1%。 华人健康最新一期业绩显示，截至2025一季报，公司营业总收入12.67亿元、同比增长14.71%，归属净 利润6122.23万元，同比增长28.15%，扣非净利润597 ...

Market Overview - The pharmaceutical commercial sector increased by 1.04% on July 30, with Huaren Health leading the gains [1] - The Shanghai Composite Index closed at 3615.72, up 0.17%, while the Shenzhen Component Index closed at 11203.03, down 0.77% [1] Top Performers - Huaren Health (301408) closed at 15.01, up 5.48% with a trading volume of 334,100 shares and a transaction value of 499 million [1] - Jiazhang Tang (002462) closed at 14.67, up 4.19% with a trading volume of 232,300 shares and a transaction value of 346 million [1] - Laobaixing (603883) closed at 19.69, up 2.93% with a trading volume of 398,800 shares and a transaction value of 779 million [1] - China National Pharmaceutical (600056) closed at 11.28, up 2.64% with a trading volume of 656,900 shares and a transaction value of 747 million [1] Underperformers - Renmin Tongtai (600829) closed at 8.77, down 7.20% with a trading volume of 724,400 shares and a transaction value of 651 million [2] - Saily Medical (603716) closed at 30.89, down 2.31% with a trading volume of 444,300 shares and a transaction value of 1.385 billion [2] - Runda Medical (603108) closed at 18.20, down 1.83% with a trading volume of 299,700 shares and a transaction value of 552 million [2] Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 62.07 million from institutional investors, while retail investors saw a net inflow of 64.93 million [2] - Major stocks like Laobaixing and China National Pharmaceutical had significant net inflows from retail investors, despite overall sector outflows [3] Individual Stock Analysis - Laobaixing (603883) had a net inflow of 62.57 million from institutional investors, but a net outflow of 45.34 million from retail investors [3] - China National Pharmaceutical (600056) saw a net inflow of 49.86 million from institutional investors, with a net outflow of 43.44 million from retail investors [3] - Huaren Health (301408) had a net inflow of 21.02 million from institutional investors, but a net outflow of 26.49 million from retail investors [3]

本文源自：金融界 最近三个交易日，25日-29日，华人健康分别获融资买入0.31亿元、0.24亿元、0.17亿元。 融券方面，当日融券卖出0.00万股，净卖出0.00万股。 7月29日，沪深两融数据显示，华人健康获融资买入额0.17亿元，居两市第2082位，当日融资偿还额0.17 亿元，净买入42.34万元。 作者：智投君 ...

资金流向方面，今日主力资金净流出2521.48万元，占比成交额14.32%。其中，超大单净流出260.77万 元、占成交额1.48%，大单净流出2260.72万元、占成交额12.84%，中单净流出流出971.82万元、占成交 额5.52%，小单净流入3493.30万元、占成交额19.84%。 通过天眼查大数据分析，安徽华人健康医药股份有限公司共对外投资了18家企业，参与招投标项目33 次，知识产权方面有商标信息156条，专利信息21条，此外企业还拥有行政许可41个。 华人健康最新一期业绩显示，截至2025一季报，公司营业总收入12.67亿元、同比增长14.71%，归属净 利润6122.23万元，同比增长28.15%，扣非净利润5970.20万元，同比增长31.11%，流动比率1.189、速动 比率0.786、资产负债率57.07%。 来源：金融界 金融界消息 截至2025年7月29日收盘，华人健康（301408）报收于14.23元，下跌1.52%，换手率8.3%， 成交量12.38万手，成交金额1.76亿元。 天眼查商业履历信息显示，安徽华人健康医药股份有限公司，成立于2001年，位于合肥市，是一家以从 事零 ...

Core Viewpoint - The company, Huaren Health, has shown a positive financial performance with significant growth in revenue and net profit, despite a relatively high PE ratio compared to the industry average [1][2]. Group 1: Financial Performance - For the fiscal year 2024, the company achieved a record revenue of 4.532 billion yuan, representing a year-on-year growth of 19.34% [1]. - The net profit attributable to the parent company was 138 million yuan, an increase of 20.09% compared to the previous year [1]. - The net profit after deducting non-recurring gains and losses was 129 million yuan, reflecting a growth of 21.81% year-on-year [1]. - In the latest quarterly report for Q1 2025, the company reported a revenue of 1.267 billion yuan, which is a year-on-year increase of 14.71% [2]. - The net profit for Q1 2025 was 61.22 million yuan, showing a year-on-year growth of 28.15% [2]. - The operating cash flow has shown continuous improvement, indicating a steady enhancement in operational quality [1]. Group 2: Market Position and Valuation - As of July 23, the company's stock closed at 14.8 yuan, with a PE ratio of 39.17, marking a new low in 17 days [1]. - The total market capitalization of Huaren Health is 5.92 billion yuan [1]. - In comparison to the pharmaceutical retail industry, the average PE ratio is 42.87, while the median is 29.04, placing Huaren Health at the 22nd position within the industry [1]. - The company has two institutional investors holding a total of 7700 shares, with a market value of 0.00 billion yuan [1].

Group 1 - The company held its 11th meeting of the 5th Board of Directors on July 18, 2025, in compliance with relevant laws and regulations [1][2] - The Board approved the proposal to change the company's registered address to "123 Hebei Road, Hefei City, Anhui Province" and to amend the corresponding clauses in the Articles of Association [1][2] - The proposal requires submission to the shareholders' meeting for further approval [2] Group 2 - The company plans to hold its third temporary shareholders' meeting on August 25, 2025, combining on-site and online voting [2] - The voting results for the proposals were unanimous with 9 votes in favor, and no abstentions or oppositions [2]

一、会议基本情况 证券代码：301408 证券简称：华人健康 公告编号：2025-054 安徽华人健康医药股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或者重大遗漏。 安徽华人健康医药股份有限公司（以下简称"公司"）于2025年7月18日召开 第五届董事会第十一次会议，审议通过了《关于提请召开2025年第三次临时股东会 的议案》，决定于2025年8月25日14:30以现场投票与网络投票相结合的方式召开公 司2025年第三次临时股东会，现将本次股东会的有关事项公告如下： 门规章、规范性文件和《公司章程》的规定。 （1）现场会议召开日期与时间：2025年8月25日（星期一）下午14:30； （2）网络投票时间： ①通过深圳证券交易所交易系统进行网络投票的具体时间为：2025年8月25日 上午9:15-9:25，9:30-11:30，下午13:00-15:00。 ②通过深圳证券交易所互联网投票系统进行网络投票的具体时间为：2025年8 月25日上午9:15至下午15:00。 公司将通过深交所交易系统和互联网投票系统（http://wltp.cninfo.com.c ...